ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DPH Dechra Pharmaceuticals Plc

3,866.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3,866.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Dechra Pharmaceuticals PLC Director/PDMR Shareholding (9666F)

26/02/2018 3:50pm

UK Regulatory


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 9666F

Dechra Pharmaceuticals PLC

26 February 2018

26 February 2018

Dechra(R) Pharmaceuticals PLC

(Dechra or the Company)

Notification and public disclosure of transactions by

persons discharging managerial responsibilities (PDMRs)

Dechra Pharmaceuticals PLC announces that on 26 February 2018, Richard Cotton exercised a nil cost option over ordinary shares of 1p each in the Company. The option was granted to him on 7 March 2017 as part of the recruitment award referred to in the Company's Directors' Remuneration Report for the year ended 30 June 2017.

The exercise of the option was subject to a performance review, as result of which the vesting percentage is 100%.

 
 Name       Capacity    Number of       Total beneficial     Percentage 
                         share over      shareholding         of issued 
                         which option    following            share 
                         exercised       this announcement    capital 
 Richard 
  Cotton    Director    21,033          42,351                0.041% 
 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial 
       Responsibility ("PDMR")/person closely 
       associated with them ("PCA") 
---  ----------------------------------------------------------------- 
 a)   Name                           Richard Cotton 
---  -----------------------------  ---------------------------------- 
 2.   Reason for the notification 
---  ----------------------------------------------------------------- 
 a)   Position/status                Director/PDMR 
---  -----------------------------  ---------------------------------- 
 b)   Initial notification/          Initial Notification 
       amendment 
---  -----------------------------  ---------------------------------- 
 3.   Details of the Issuer 
---  ----------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
---  -----------------------------  ---------------------------------- 
 b)   LEI code                       213800J4UVB5OWG8VX82 
---  -----------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ----------------------------------------------------------------- 
 a)   Description                    Ordinary Shares of 1 pence 
       of the financial               each 
       instrument 
 
       Identification                 ISIN: GB0009633180 
       code 
---  -----------------------------  ---------------------------------- 
 b)   Nature of                      Exercise of an option granted 
       the transaction                as part of a recruitment award 
                                      to acquire 21,033 shares 
---  -----------------------------  ---------------------------------- 
 c)   Price(s) and                   Price(s)             Volume(s) 
       volumes(s) 
                                      GBPNil Cost          21,033 
---  -----------------------------  -------------------  ------------- 
 d)        Aggregated 
            information 
             *    Aggregate volume     N/A 
 
 
             *    Price 
---  -----------------------------  ---------------------------------- 
 e)   Date of the                    2018.02.26 
       transaction 
---  -----------------------------  ---------------------------------- 
 f)   Place of the                   Outside a trading venue 
       transaction 
---  -----------------------------  ---------------------------------- 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFKADQPBKDFBB

(END) Dow Jones Newswires

February 26, 2018 10:50 ET (15:50 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock